Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -16.75% is 877% below its 5-year average of -1.72%, around the middle of its 5-year range (-59.26%–10.59%).
13.84% below its 12-month average of -14.71%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -59.26%.
NET PROFIT MARGIN
-16.75%
NET PROFIT MARGIN AVG TTM
-14.71%
NET PROFIT MARGIN AVG 3Y
-2.91%
NET PROFIT MARGIN AVG 5Y
-1.72%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-13.84%
CURRENT VS 3Y AVG
-475.84%
CURRENT VS 5Y AVG
-876.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Certara, Inc.
Market Cap
$1.54B
Net Profit Margin
-16.75%
TTM Avg
-14.71%
3Y Avg
-2.91%
5Y Avg
-1.72%
Market Cap
$1.53B
Net Profit Margin
80.56%
TTM Avg
35.15%
3Y Avg
48.19%
5Y Avg
54.54%
Market Cap
$1.50B
Net Profit Margin
12.02%
TTM Avg
-7.78%
3Y Avg
-15.24%
5Y Avg
-11964.64%
Market Cap
$1.47B
Net Profit Margin
6.59%
TTM Avg
2.75%
3Y Avg
2.46%
5Y Avg
3.07%
Market Cap
$1.46B
Net Profit Margin
-667.95%
TTM Avg
15.59%
3Y Avg
7.79%
5Y Avg
7.79%
Market Cap
$1.43B
Net Profit Margin
82.37%
TTM Avg
-82.37%
3Y Avg
-592.43%
5Y Avg
-414.63%
Market Cap
$1.65B
Net Profit Margin
10.82%
TTM Avg
2.93%
3Y Avg
-1.36%
5Y Avg
-5.99%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.54B | -16.75% | -14.71% | -2.91% | -1.72% |
| Innoviva, Inc. (INVA)vs › | $1.53B | 80.56% | 35.15% | 48.19% | 54.54% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 12.02% | -7.78% | -15.24% | -11964.64% |
| GH Research PLC (GHRS)vs › | $1.49B | 0.00% | 0.00% | 0.00% | 0.00% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 6.59% | 2.75% | 2.46% | 3.07% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.46B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | -667.95% | 15.59% | 7.79% | 7.79% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 82.37% | -82.37% | -592.43% | -414.63% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 10.82% | 2.93% | -1.36% | -5.99% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -13.50% | -22.64% | -31.77% | -40.07% |
Operating Margin
1.9%
Net Profit Margin
-16.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -59.26% |
| 2026-03-31 | -8.20% |
| 2025-12-31 | -5.69% |
| 2025-09-30 | 1.46% |
| 2025-06-30 | -1.88% |
| 2025-03-31 | 4.47% |
| 2024-12-31 | 6.55% |
| 2024-09-30 | -1.45% |
| 2024-06-30 | -13.48% |
| 2024-03-31 | -4.85% |
| 2023-12-31 | -14.15% |
| 2023-09-30 | -57.22% |
| 2023-06-30 | 5.20% |
| 2023-03-31 | 1.50% |
| 2022-12-31 | 10.59% |
| 2022-09-30 | 4.65% |
| 2022-06-30 | -0.71% |
| 2022-03-31 | 2.71% |
| 2021-12-31 | -12.87% |
| 2021-09-30 | -2.38% |
| 2021-06-30 | -4.08% |
| 2021-03-31 | 1.58% |
| 2020-12-31 | -84.23% |
| 2020-09-30 | 2.03% |
| 2020-06-30 | 4.54% |
| 2020-03-31 | 1.82% |
| 2019-12-31 | -11.17% |
| 2019-09-30 | 5.22% |
| 2019-06-30 | -5.64% |
| 2019-03-31 | -5.64% |
